Tela Bio Inc Reports Results For The Quarter Ended In September: Earnings Summary

TELA Bio

09/11/2022 22:03

* TELA Bio Inc  TELA.OQ  reported a quarterly adjusted loss
of 64
cents​​ per share for the quarter ended in September. The mean
expectation of five analysts for the quarter was for a loss
of 63 cents per share.
    * Revenue rose 45.8% to $11.16 million from a year ago;
analysts
expected $10.87 million. 
    * TELA Bio Inc's reported EPS for the quarter was a loss
of 64
cents​.
    * The mean earnings estimate of analysts had fallen by
about 2% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * TELA Bio Inc shares had fallen by 16.4% this quarter and
lost 44.4% so far this year.
    * The company reported a quarterly loss of $10.71 million.
    * Wall Street's median 12-month price target for TELA Bio
Inc is
$20.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 10:03 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.63          -0.64          Missed
 Jun. 30 2022      -0.62          -0.79          Missed
 Mar. 31 2022      -0.56          -0.75          Missed
 Dec. 31 2021      -0.55          -0.59          Missed